Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
Celgene
Baker, Malcolm P.; McComb, Emily R.Caso HBS-218094-EFinanzasIn February 2011, Adam Koppel, a Managing Director at Brookside Capital, the public equity arm of Bain Capital, must decide whether to increase or exit the firm's position in Celgene Corporation. News has emerged that raises potential safety concerns associated with Celgene's key drug, Revlimid. In response, Celgene's share price has traded down 20% in the last two months, and is now almost 10% below the level where Brookside made their initial i...Desde 8,20 €
-
Celgene (B)
Baker, Malcolm P.; McComb, Emily R.Caso HBS-218099-EFinanzasIn February 2011, Adam Koppel, a Managing Director at Brookside Capital, the public equity arm of Bain Capital, must decide whether to increase or exit the firm's position in Celgene Corporation. News has emerged that raises potential safety concerns associated with Celgene's key drug, Revlimid. In response, Celgene's share price has traded down 20% in the last two months, and is now almost 10% below the level where Brookside made their initial i...Desde 5,74 €
-
Fonderia del Piemonte S.p.A - Teaching Note
Bruner, Robert F.; Schill, Michael J.Nota del Instructor DARDEN-F-1764TN-EFinanzasTeaching note for product F-1764Desde 0,00 €
-
Fonderia del Piemonte S.p.A.
Bruner, Robert F.; Schill, Michael J.Caso DARDEN-F-1764-EFinanzasThe managing director of this specialty foundry must decide whether to approve a major investment to automate part of her plant’s production process. The case presents information sufficient to build cash-flow forecasts of production costs incremental to this investment. Discounted cash flow (DCF) analysis reveals that this investment project is attractive but that the benefits hinge on important assumptions about the plant’s business volume, the...Desde 8,20 €